Lipocine Inc. Made Headway
Tue, May 23, 2023 at 07:49 PM
Lipocine Inc. (LPCN:NASDAQ) jumped higher at $5.37, representing a gain of 32.3%. On Tue, May 23, 2023, LPCN:NASDAQ hit a New 2-Week High of $5.37. The stock got featured on our News Catalysts scanner on Tue, May 16, 2023 at 07:17 AM in the 'BIOTECH' category. From Tue, May 09, 2023, the stock recorded 70.00% Up Days and 81.82% Green Days
About Lipocine Inc. (LPCN:NASDAQ)
Lipocine Inc is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men's and women's health.
Top 10 Gainers:
- Heartcore Enterprises Inc. (HTCR:NASDAQ), 92.19%
- Lifecore Biomedical Inc Com (LFCR:NASDAQ), 50.19%
- Shuttle Pharmaceuticals Holdings Inc. (SHPH:NASDAQ), 45.19%
- SeqLL Inc. (SQL:NASDAQ), 40.25%
- Lipocine Inc. (LPCN:NASDAQ), 32.27%
- mCloud Technologies Corp. (MCLD:NASDAQ), 30.74%
- Alpha Teknova Inc. (TKNO:NASDAQ), 28.92%
- Ocean Biomedical Inc Com (OCEA:NASDAQ), 28.14%
- Aptinyx Inc. (APTX:NASDAQ), 27.87%
- Applied UV Inc. (AUVI:NASDAQ), 25.79%